Jeroen C. Verheijen

Biochemical, Cellular, and <i>In vivo</i> Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin

Ker Yu, Lourdes Toral‐Barza, Celine Shi et al. · Cancer Research · 2009 · 330 citations

Medicine, Oncology, Pharmacology +13

Beyond Rapalog Therapy: Preclinical Pharmacology and Antitumor Activity of WYE-125132, an ATP-Competitive and Specific Inhibitor of mTORC1 and mTORC2

Ker Yu, Celine Shi, Lourdes Toral‐Barza et al. · Cancer Research · 2010 · 208 citations · Full text

Medicine, Oncology, Pharmacology +14

ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin: Design and Synthesis of Highly Potent and Selective Pyrazolopyrimidines

Arie Zask, Jeroen C. Verheijen, Kevin J. Curran et al. · Journal of Medicinal Chemistry · 2009 · 98 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Morpholine Derivatives Greatly Enhance the Selectivity of Mammalian Target of Rapamycin (mTOR) Inhibitors

Arie Zask, Joshua A. Kaplan, Jeroen C. Verheijen et al. · Journal of Medicinal Chemistry · 2009 · 97 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Transition Metal Derivatives of Peptide Nucleic Acid (PNA) OligomersSynthesis, Characterization, and DNA Binding

Jeroen C. Verheijen, Gijsbert A. van der Marel, Jacques H. van Boom et al. · Bioconjugate Chemistry · 2000 · 85 citations

Natural Sciences, Chemistry, Molecular Biology +17